Marlena Keisler, n/a

Vedanta Biosciences
Cambridge, Massachusetts, United States

Disclosure(s): Vedanta Biosciences: Employer

Presentation(s):

• 377 - Impact of VE303, a Defined Bacterial Consortium, on Antimicrobial Resistant Gene Prevalence in Patients with Clostridioides difficile Infection (CDI)

  Friday, October 18, 2024
  1:57 PM – 2:09 PM US PT